DURECT Temettü

Temettü kriter kontrolleri 0/6

DURECT does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

-3.8%

Geri Alım Getirisi

Toplam Hissedar Getirisi-3.8%
Gelecekteki Temettü Verimin/a
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Ödeme oranın/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts

Aug 08
Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts

Durect names ex-RBC Capital Markets executive as CFO

Jul 05

Is DURECT (NASDAQ:DRRX) A Risky Investment?

May 12
Is DURECT (NASDAQ:DRRX) A Risky Investment?

DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be

Mar 14
DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be

DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 10
DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Jan 08
Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Aug 05
Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Durect (DRRX) Investor Presentation - Slideshow

May 06

Durect EPS misses by $0.01, misses on revenue

May 04

DURECT prices ~$43M stock offering

Feb 04

DURECT surges after FDA approval for Posimir

Feb 02

Durect's DUR-928 fast track'd for alcoholic hepatitis in the U.S.

Dec 16

DURECT (DRRX) Investor Presentation - Slideshow

Oct 31

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if DRRX's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if DRRX's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

DURECT Piyasaya Karşı Temettü Getirisi
DRRX temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (DRRX)n/a
Pazarın Alt %25'i (US)1.5%
Pazarın En İyi %25'i (US)4.5%
Sektör Ortalaması (Pharmaceuticals)2.3%
Analist tahmini (DRRX) (3 yıla kadar)n/a

Önemli Temettü: Unable to evaluate DRRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate DRRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate DRRX's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as DRRX has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin